Tamboran files supplement for 2,956,602-share offering

Tamboran Resources Corporation filed a supplement to its prospectus supplement dated April 7, 2026 relating to the registration of 2,956,602 shares of common stock.

Rhea-AI Filing Summary

Tamboran Resources Corporation filed a supplement to its prospectus supplement dated April 7, 2026 relating to the registration of 2,956,602 shares of common stock. The supplement notes that the amount would be 3,400,093 shares if the underwriters' over-allotment option is exercised in full.

The filing is limited to submitting the Exhibit 107 filing fee exhibit for the underwriters' over-allotment option and does not amend the prior prospectus supplement or the accompanying prospectus.

Key Figures

Registered shares: 2,956,602 shares Maximum if greenshoe exercised: 3,400,093 shares

2 metrics

Registered shares 2,956,602 shares relating to prospectus supplement dated April 7, 2026

Maximum if greenshoe exercised 3,400,093 shares if the underwriters' over-allotment option is exercised in full

Key Terms

underwriters' over-allotment option, prospectus supplement, Exhibit 107 filing fee exhibit

3 terms

underwriters' over-allotment option financial

"relating to 2,956,602 shares of common stock, (3,400,093 if the underwriters' over-allotment"

prospectus supplement regulatory

"prospectus supplement, dated April 7, 2026 (File No. 333-294908), filed by Tamboran"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Exhibit 107 filing fee exhibit regulatory

"filed solely for the purposes of filing the Exhibit 107 filing fee exhibit"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Tamboran's supplement say about the number of shares being registered (TBN)?

The supplement registers 2,956,602 shares of common stock. It states this would increase to 3,400,093 shares if the underwriters' over-allotment option is exercised in full, per the prospectus supplement dated April 7, 2026.

Does the supplement change the original prospectus supplement terms for Tamboran (TBN)?

No. The supplement expressly states it does not amend, modify or alter the prior prospectus supplement or the accompanying prospectus; it is filed solely to provide the Exhibit 107 filing fee exhibit for the over-allotment option.

What is the purpose of the Exhibit 107 filing referenced in Tamboran's supplement (TBN)?

The filing submits the Exhibit 107 filing fee exhibit related to the underwriters' over-allotment option described in the prospectus supplement. The supplement indicates this is the sole purpose and makes no other changes to the offering documents.

When was the related prospectus supplement for Tamboran (TBN) originally dated?

The related prospectus supplement is dated April 7, 2026. The supplement being filed references that prospectus supplement and confirms no substantive changes were made to it or the accompanying prospectus.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 06:15 AM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5) and 424(b)(8)

Registration No. 333-294908

SUPPLEMENT TO PROSPECTUS SUPPLEMENT DATED APRIL 7, 2026

(To Prospectus dated April 7, 2026)

EXPLANATORY NOTE

This supplement is being filed solely for the purposes of filing the Exhibit 107 filing fee exhibit with respect to the underwriters’ over-allotment option as described in the prospectus supplement, dated April 7, 2026 (File No. 333-294908), filed by Tamboran Resources Corporation with the Securities and Exchange Commission relating to 2,956,602 shares of common stock, $0.001 par value per share (3,400,093 if the underwriters’ over-allotment option is exercised in full). This filing does not amend, modify or alter such prior filing in any other respect. No changes have been made to the prospectus supplement or the accompanying prospectus.